Internal Medicine

Thank you for your interest in the Internal Medicine Residency Program at Mount Sinai Medical Center.

As the largest private, independent, not-for-profit teaching hospital in South Florida, our 672-bed facility delivers the most advanced and highest quality care in the region. Our attending physicians share a passion for academic internal medicine and medical education. We provide a strong academic foundation for resident training in a supportive learning environment. Our residents’ experiences are supplemented by a strong community base of subspecialty physicians who further augment residency training at Mount Sinai Medical Center through electives, hospital-based clinics, consultations, and research mentorship. Residents also have the opportunity to broaden their clinical experience through rotations at the nearby Jackson Memorial Hospital.

As an academic training site, there are numerous opportunities for our residents to develop their aptitude for teaching. Mount Sinai has a longstanding tradition of medical education excellence. With an education program founded in 1953, the medical center is one of Florida’s original statutory teaching hospitals. Mount Sinai has academic affiliations with the University of Miami, Florida International University’s Herbert Wertheim College of Medicine, Nova Southeastern University’s Dr. Kiran C. Patel Colleges of Osteopathic and Allopathic Medicine, Columbia University Vagelos College of Medicine and medical students from all these schools rotate through our internal medicine program. Our residents also interact with other residents from different specialties, including radiology, pathology, urology, anesthesia, surgery, podiatry, gynecology, psychiatry, as well as fellows in cardiology, infectious diseases, and pulmonary/critical care.

Our residents are exposed to a great variety of patients and pathology during their training. As the only hospital in Miami Beach, with a network of physician offices and freestanding emergency departments throughout Miami-Dade and Monroe Counties, we serve residents from all over the region as well and great number of visitors from South America and overseas. Residents are exposed to the common internal medicine pathology and to unique pathology from other countries, including malaria, leishmaniasis, dengue, zika, HIV, and tuberculosis. Additionally, our hospital is home to one of the most advanced and highest volume heart programs in South Florida.

Residents progressively advance through their internal medicine rotations during their three years of training, and are capable of practicing independently by the end of training. They also have exposure to a very active critical care service over the course of training, with increasing responsibility over the three years. Residents are exposed to all core internal medicine rotations during their training. We have a strong outpatient department, and all residents develop a continuity clinic over the three years, as well as participate in QI projects.

Our program boasts a board pass rate of over 94%, which is above the national average, and an acceptance rate of over 90% to fellowship programs. Each year, we graduate 14 residents plus three residents that stay as 4th year chief resident/junior attending. Every year an average of 60% of our graduating residents continue their training in subspecialty fellowships.

At Mount Sinai Medical Center, we are committed to providing excellence in patient care and physician training and education. Our role is to provide you with the best possible environment to allow you to grow as an individual and to acquire the information necessary to become an exemplary physician. We have adapted our academic and rotation infrastructure post-COVID-19 to incorporate safe and effective means to care for patients while protecting your health and maintaining a strong academic curriculum.

You are about to begin one of the most exciting and rewarding chapters of your career as a physician. We believe that Mount Sinai Medical Center is the ideal environment to allow you to become the best you can be, and we look forward to helping you achieve your professional goals.

Sincerely,

Claudio Tuda, MD, FACP
Program Director, Internal Medicine Residency

The Internal Medicine Residency Program at Mount Sinai Medical Center is committed to excellence in the training and education of physicians for the practice of primary care, general internal medicine and its subspecialties. When residents graduate from this three-year program, they can transition into clinical practice or fellowship training with competency, confidence and success.

Teaching Philosophy

At Mount Sinai Medical Center, we stress the physician’s primary obligation to patient care and patient advocacy. Residents accept progressive responsibility in an environment that is dedicated to their supervision and support.

Our program maintains an atmosphere that is supportive and conducive to learning, ensuring that each resident has the opportunity to develop the skills to achieve his or her individual career goals. Residents are allowed the opportunity to plan their schedules so that their specific needs and interests are met. Our excellent 24-hour ancillary support services ensure that residents may focus their time on patient care and formal learning activities. Our commitment to hands-on and didactic instruction is reflected in our superb American Board of Internal Medicine (ABIM) examination pass rate.

Residency Management Team

The program director and faculty maintain an open door policy to address any issues. The Residency Management Team (RMT), comprised of the program director, associate program directors, program coordinators, chief residents and core faculty, meet weekly to address all aspects of the program. A clinical competency committee composed of select faculty members meet quarterly to review the progress of house staff and to identify any resident performance issues or unmet needs.

House Staff Benefits

Residents are provided with:

• 21 days paid vacation as PGY-1, 28 days paid vacation as PGY-2 & 3
• 14 paid sick days
• Academic Stipend: $2,000
• Conference Stipend: $2,000 – Can be utilized for three conferences yearly
• Two White PGY-1 year. One white coat annually thereafter
• On-call rooms for overnight shifts
• Covered parking
• House staff lounge with TV, refrigerator, and computer stations
• Professional liability insurance

Residents are eligible for:

• Health insurance for resident and dependents
• Dental insurance
• Life insurance
• Long-term disability insurance

Education and Teaching Conferences

Our program organizes a variety of lectures, conferences, and experiences for the benefit of our residents. Each month is dedicated to specific medicine subspecialties with lectures organized by a combination of senior residents and faculty.

Morning Report – 8:00 AM – 9:00 AM

• Intern Morning Report: Monday – Tuesday
  • Hosted every Monday and Tuesday. Review of fundamental internal medicine topics and basic skills interns must develop in their first year.
• Resident Morning Report: Wednesday
  • Small group discussion format for PGY-2s and PGY-3s under the direct supervision of the program director reviewing the management of difficult cases and advanced differential diagnoses
• Combined Morning Report: Thursday
  • Conference for all on-site residents on various topics including journal club, guideline reviews, or mini-grand rounds on special topics.

Noon conference: 12:00 PM – 1:00 PM

• Program Director Report: Monday
  • Case Presentation to the program director with accompanying group discussion
• Tuesday – Thursday
  • Resident-led board review
  • Faculty and fellow led subspecialty conference.
  • Interesting Case presentations
  • Recurring monthly conferences
    • ECG conference
    • Grand Rounds
    • M&M
    • ID Conference
    • Ultrasound Conference

Sim lab

• Recurring weekly sessions Thursday afternoons under the direction of sim lab coordinator with a progressive curriculum.

Ultrasound Curriculum

• Monthly didactic conferences by associate program director related to subspecialty block
• Weekly skills sessions in small group format during ambulatory block
• Handheld ultrasound device available to all residents
• Access to dedicated ICU ultrasounds
• Opportunity to create POCUS portfolio
• Optional electives rotation in partnership with ultrasound fellowship

PGY-1 Year

During their first year, residents will establish the foundation of their clinical knowledge and practice. The majority of intern year will be dedicated to the management of patients on the inpatient teaching service wards where they will be exposed to a wide range of pathologies and work with a team consisting of a co-intern and senior resident. The remainder of the schedule is divided into night rotations, MICU, continuity clinic, selective rotations, and electives.

• Wards: 14 – 16 weeks
• Clinic 10-11 Weeks
• Medical ICU: 5 Weeks
• Wards Night Float: 2 – 3 Weeks
• MICU Night Float: 4-5 Weeks
• Emergency Department: 4 Weeks
• Surgical ICU: 1 Week
• Pathology: 1 Week
• Elective: 5 weeks
• Vacation: 3 Weeks

PGY-2 Year

In their second year, residents will transition to a leadership and teaching role. As seniors on the wards they will be in charge of leading the team and supervising interns. Senior residents are additionally expected to contribute to our didactic education by leading various conferences throughout the year. Second years will spend less time on the wards service and instead gain experience in various internal medicine subspecialties through selective rotations including:

• Cardiology
• Endocrinology
• Gastroenterology
• Infectious Disease

Second year residents will additionally have the opportunity to augment their outpatient education by participating in optional subspecialty clinic half-days.

Second year residents are expected to lead quality improvement projects which they will present at ground rounds at the end of the academic year

PGY-3 Year

During third year, residents will continue to solidify their knowledge and role as leaders within the program. Additional subspecialty exposure will continue through selective rotations:

• Geriatrics
• Cardiac Critical Care
• Outpatient gastroenterology
• Cardiology

Preliminary Medicine Internship Year

Mount Sinai Medical Center offers four positions to those who are seeking a preliminary medicine year. We offer our preliminary year residents the tools to excel in their eventual career goals, with a strong foundation in Internal Medicine. Admission into our program is extremely competitive and draws the strongest of candidates. If you have excelled thus far and are looking for a challenging program in a fantastic setting, we encourage you to apply.

Preliminary year residents participate in the same curriculum as our categorical residents.

Ambulatory Experience

Residents follow a 4 + 1 schedule, in which 4 weeks are spent on an inpatient service, and the 5th week is spent in one of our outpatient clinics. During this time, residents are provided with 1:1 supervision by an attending while they see and care for their own patients. All of our clinics are located within a 20-minute radius of main campus including Hialeah, Sunny Isles, Aventura, Coral Gables, Key Biscayne, Midtown and Skylake.

Fundamental Friday

Ambulatory didactics are held weekly on Fridays for those on their clinic blocks. Residents are excused from clinical duties during this academic day.

Sessions Include:

• Ambulatory Morning Report
• POCUS Skills Session
• Wellness/Lifestyle Medicine Curriculum
• Yoga/Sound Meditation
• Integrative Lecture/Guideline Review
• Guided exercises and discussions with mental health professionals
• Therapy Dogs
• Art therapy

Lifestyle Medicine Curriculum

We are the only program in South Florida offering access to the American College of Lifestyle Medicine official curriculum. The curriculum includes material related to the treatment of chronic disease through diet, exercise and sleep prescriptions with the opportunity to sit for board certification in lifestyle medicine on completion of a continuous three-year didactic curriculum.

Career Guidance

A priority in our program is to assist residents in choosing the careers they are best suited for and in which they will be happy. Flexibility in elective scheduling permits residents to gain exposure to subspecialties of potential interest as early as the PGY-1 term. Program leadership makes every effort to help residents with the pursuit of their career goals, directing them towards appropriate faculty members to serve as mentors and fellowship advocates. Mentors may be reassigned, as needed, to accommodate residents’ interests if they evolve during the course of training.

Residency Management Team

Claudio Tuda MD, FACP – Program Director

• Program Director, Internal Medicine Residency
• Chief of Infectious Disease
• Hospital Epidemiologist
• Associate Professor of Nova Southeastern Universty Dr. Kiram C. Patel College of Osteopathic and Allopathic Medicine
• Associate Professor of Florida International
• Medical School: University of Buenos Aires
• Residency: Mount Sinai Medical Center, FL
• Fellowship: University of Miami – Jackson Memorial Hospital
• Specialty: Internal Medicine, Infectious Diseases

Cynthia Rivera MD, FACP – Associate Program Director

• Associate Program Director, Internal Medicine Residency
• Program Director, Infectious Disease Fellowship
• Medical School: University of Nebraska Medical Center
• Residency: Jackson Memorial Hospital/University of Miami
• Fellowship: Jackson Memorial Hospital/University of Miami
• Specialty: Internal Medicine, Infectious Diseases

Maykel Trotter MD, FACP – Associate Program Director

• Associate Program Director, Internal Medicine Residency
• Medical School: St. Matthews University, Grand Cayman
• University of Havana School of Medicine
• Residency: Mount Sinai Medical Center, FL
• Specialty: Internal Medicine, Concierge Medicine

Ariel Reines MD

• Division of Internal Medicine
• Medical School: Albert Einstein College of Medicine
• Residency: Mount Sinai Medical Center, FL
• Specialty: Internal Medicine

Diego Lugo MD, FACP

• Medical School: Universidad Autonoma de Guadalajara
• Residency: Mount Sinai Medical Center
• Specialty: Internal Medicine, Hospitalist

Carolina De La Cuesta MD

• Chief of Critical Care Division Associate Program Director: Pulmonary Critical Care Fellowship
• Medical School: Universidad del Norte
• Residency: Mount Sinai Medical Center
• Fellowship: University of Miami- Jackson Memorial Hospital
• Specialty: Internal Medicine, Critical Care, Infectious Disease

Alba Gonzalez-Ochoa MD

• Medical school: Universidad Autónoma de Baja California
• Residency: Jackson Memorial Hospital/University of Miami
• Fellowship: Jackson Memorial Hospital/University of Miami
• Specialty: Internal Medicine, Nephrology and Hypertension

Molly Bilderback DO

• Hospitalist Physician
• Medical School: Nova Southeastern University
• Residency: Mount Sinai Medical Center
• Specialty: Internal Medicine, Hospitalist

Nicholas Camps DO

• Medical School: Nova Southeastern University
• Residency: Palmetto General Hospital
• Fellowship:  University of Miami- Jackson Memorial Hospital
• Specialty: Internal Medicine, Infectious Disease

PGY -1

Preliminary Residents

Brian Zacharias, DO
Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine

Bryce Sebade, DO
Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine

Raj Kavadi, DO
Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine

Wasila Daas, MD
Al-Baath University Faculty of Medicine

Categorical

Alex Breslau, DO
Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine

Ariel Schneier, MD
Rutgers, Robert Wood Johnson Medical School

Arnold Ocoro, MD
Universidad Santiago de Cali Facultad de Salud

Alexa Lowe, DO
Touro College of Osteopathic Medicine

Daniel Epstein, DO
Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine

Daniela Whilchy, MD
Universidad de Carabobo Facultad de Ciencias de la Salud

Daria Bekina, MD
St. Petersburg National Research Institute of Infectious Diseases Tyumen State Medical University

Donna Abboud, MD
LAU Gilbert and Rose-Marie Chagoury School of Medicine   

Florencia Mitchell, MD
Instituto Universitario CEMIC Escuela de Medicina Argentina

Johan Diaz, MD
Geisinger Commonwealth School of Medicine

Matthew Ghermezi, MD
Florida International University – Herbert Wertheim College of Medicine

Mohamed Douedari, MD
University of Aleppo Faculty of Medicine Syrian Arab Republic

Neil Chokshi, DO
Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine

Nico Munley, DO
Philadelphia College of Osteopathic Medicine

Rachel Shatanof, MD
Florida International University Herbert Wertheim College of Medicine

Vania Rodriguez, MD
Universidad Católica Nuestra Señora de la Asunción Facultad de Ciencias de la Salud

Victor Guillen, MD
Universidad de Carabobo Facultad de Ciencias de la Salud

PGY2

Alexandra Lyubimova, DO
Nova Southeastern University College of Osteopathic Medicine

Alexandria Alvarez, MD
Florida International University – Herbert Wertheim College of Medicine

Andres Alvarez, MD
Universidad Central de Venezuela Escuela de Medicina

Awana Chowdhury, DO
Nova Southeastern University College of Osteopathic Medicine

Christy Sanchez, DO
Nova Southeastern University College of Osteopathic Medicine USA

Fernando Poli, MD
Universidad Central de Venezuela Escuela de Medicina

Francy Vivas, MD
Universidad Centro-Occidental Lisandro Alvarado Decanato de Ciencias de la Salud

Freddie Prieto, DO
Nova Southeastern University College of Osteopathic Medicine

Lynda Marie Ostermann, MD
Universidad Autonoma de Guadalajara

Matthew LeSieur, DO
Nova Southeastern University College of Osteopathic Medicine USA

Monica Cabrera, DO
Nova Southeastern University College of Osteopathic Medicine

Velagapudi, Pallavi, DO
Nova Southeastern University College of Osteopathic Medicine

Premalkumar Patel, MD
Smolensk State Medical University, Smolensk, Russia

Robert Peaden, MD
University of Miami Leonard M. Miller School of Medicine

Petit, Ryan, DO
Nova Southeastern University College of Osteopathic Medicine

Hartman, Steven, MD
Nova Southeastern University College of Allopathic Medicine

Singh, Yavani, MD
Medical University of the Americas

PGY -3

Carlos Peña, MD
Universidad Central de Venezuela Escuela de Medicina

Chunnu Li, MD
Norman Bethune College of Medicine, Jilin University

Crystal Acosta, DO
Nova Southeastern University College of Osteopathic Medicine

Cynthia Espinosa, DO
Nova Southeastern University College of Osteopathic Medicine

Daniela Bignoli, MD
Universidad de Buenos Aires Facultad de Medicina

Esha Vallabhaneni, DO
Nova Southeastern University College of Osteopathic Medicine

Estefania Cecilio, MD
Universidad de Carabobo Facultad de Ciencias de la Salud, Valencia

Gisel P Urdaneta, MD
Universidad Central de Venezuela Escuela de Medicina Jose Maria Vargas

Hubert Golingan, MD
University of the East/Ramon Magsaysay Memorial Medical Center College of Medicine

Laura Mendez , MD
Universidad Iberoamericana (UNIBE) School of Medicine, Santa Domingo

Logan Schamber, DO
Nova Southeastern University College of Osteopathic Medicine  

Lorena Rojas
Universidad de Carabobo Facultad de Ciencias de la Salud, Valencia

Niketa Kalara, MD
 K.J. Somaiya Medical College, India

Maria Ibaňez, MD
Case Western Reserve University School of Medicine

Simon Gaviria, MD
Universidad CES Escuela de Medicina, Colombia

Tesil Sani , MD
Jubilee Mission Medical College and Research Institute

Yasmin Alwash, MD
University of Baghdad College of Medicine

PGY-4 Chief Residents

Andres J Azuero MD
Pontificia Universidad Javeriana

Daniel A Acosta DO
Touro University Nevada College of Osteopathic Medicine

Megan McGill DO
Nova Southeastern University College of Osteopathic Medicine

Weekly Resident Meetings

The Program Director, Associate Program Director and chief residents meet weekly with all available residents to discuss systems issues and any concerns about the training program. Free discussion is encouraged, plans of action to resolve problems are developed and follow-up is provided. This involvement by house staff is considered essential to the success of the program and is an important part of the performance improvement process for the hospital. Additionally, program leadership maintains an “open door policy” at all times, welcoming impromptu meetings with individual residents to discuss any concerns in a congenial, non-threatening atmosphere.

Alumni

2022 – 2023

Preliminary Year Graduates

Austin Pourmoussa MD
Radiology
Mount Sinai Medical Center of Florida – Miami Beach, FL

Benjamin Sussman MD

Tomas Farfan MD
Anesthesiology Residency
Mount Sinai Medical Center of Florida

Categorical Graduates

Adam Jacobs DO
Rheumatology
HCA Florida Bayonet Point Hospital – Hudson, FL

Cesar Zambrano MD
Hospitalist Physician
Adventhealth Gordon – Calhoun, GA

Claudia Perez-Acosta MD
Hospitalist Physician
Baptist Health – Miami, FL

Everett Rogers DO
Cardiology Fellowship
HCA Healthcare/USF Morsani GME – Largo, FL

Douglas Salguero MD
Cardiology Fellowship
Texas Tech University – Lubbock, TX

Fabiana Vastola MD
Primary Care Physician
Chen Senior Medical Center – Miami, FL

Juliana Guerra MD
Endocrinology Fellowship
Cleveland Clinic – Cleveland, Ohio

Lee Seifer MD
Pulmonary/Critical Care Fellowship
University of Miami/Jacksin – Miami, FL

Marissa Donatelle MD
Cardiology Fellowship
Mount Sinai Medical Center of Florida – Miami Beach, FL

Michelle Yousefzadeh DO
Infectious Disease Fellowship
University of California – Los Angeles, CA

Mohamed Elajami MD
Hospitalist Physician
Hartford Hospital – Hartford, CT

Susanna Barreiro Sacco DO
Endocrinology Fellowship
University of Miami/Jackson – Miami, FL

Veronica A Guerra MD
Hematology/Oncology Fellowship
Washington University – St Louis, MO

2021 – 2022

Preliminary Year Graduates

Emily Lowery DO
Radiology Residency
Loyola University Medical Center – Chicago, Illinois

John John Machado MD
Radiology Residency
Mount Sinai Medical Center of Florida – Miami Beach, FL

Kayla Fourzali MD
Dermatology Residency
University of South

Yasmin Alwash MD
Internal Medicine Residency
Mounts Sinai Medical Center of Florida

Categorical Graduates

Abed Aljamal MD
Hematology/Oncology Fellowship
University of South Carolina – Charleston, SC

Adolfo Alvarez DO
Pulmonary/Critical Care Fellowship
Mount Sinai Medical Center of Florida – Miami Beach, FL

Aliya Rehman DO
Infectious Disease Fellowship
University of Miami/Jackson

Ana Armas MD
Primary Care Physician
Alma Medical Center –Miami Beach, FL

Angel Porras ND
Infectious Disease Fellowship
University of Miami/Jackson – Miami, FL

Anna Willet MD
Hepatology Fellowship
Nebraska Medical Center – Omaha, Nebraska

Ayoola Olayiwola MD
Hospitalist Physician
University of Miami – Miami, FL

Ephraim Mansour MD
Chief Resident 2022-2023
Pulmonary Critical Care Fellowship
University of Florida – Gainesville, FL

Isabela Saba MD
Primary Care Physician
Providence, Rhode Island

Janine Suarez MD
Endocrinology Fellowship
University of Florida – Gainesville, FL

Jonathan Ambut MD
Clinical Informatics Fellowship
Stony Brook Hospital – Stony Brook, NY

Luisa Quesada Arias MD
Pulmonary/Critical Care Fellowship
Brigham & Women’s Hospital Harvard – Boston, MA

Rima Rida
Hospitalist Physician
Henry Ford Hospital – Detroit, Michigan

Ruben Porudominksy Rostain
Chief Resident 2022 – 2023
Cardiology Fellowship
Ochsner Medical Center – New Orleans, LA

Serio Poli de Frias
Pulmonary Critical Care Fellowshio
Brigham & Women’s Hospital Harvard – Boston, MA

Valentina Celis
Endocrinology Fellowship
University of South Florida – Tampa, FL

Zuleikha Muzaffar
Chief Resident 2022-2023
Pulmonary Critical Care Fellowship
University of Massachusetts Chan School of Medicine – Worcester, Massachusetts

2020– 2021

Lorenzo Joaquin Diaz, DO
Physical Medicine & Rehabilitation, University of Miami/ Jackson Health Care System, Miami, FL

Faris Ziad Hawatmeh, DO MHA
Dermatology, Larkin Palm Springs, Miami, FL

Julia Bini Viotti, MD
Infectious Disease

Sarah Chhabra, MD
Endocrinology, University of Massachusetts, Worcestor, MA

Nathaly Cortez Bazan, MD
Gastroenterology, University of Miami/ Jackson Health Care System, Miami, FL

Alexandra DeQuesada, MD
Chief Resident, Mount Sinai Medical Center, FL

Levi Diaz, MD
Primary Care, Providence, RI

Joshua Durbach, MD
Anesthesiology, Mount Sinai Medical Center, FL

Kathrin Dvir, MD
Hematology/ Oncology, St. Elizabeth Medical Center, Boston, MA

Anthony Febres Aldana, MD
Infectious Disease, Baylor/ MD Anderson, Houston, TX

Gliceida Galarza Fortuna, MD
Chief Resident, Mount Sinai Medical Center, FL

Medeona Gjergjindreaj, DO
Cardiology, Mount Sinai Medical Center, FL

Lizy Paniagua Gonzalez, MD
Infectious Disease, University of Miami/ Jackson Healthcare System, Miami, FL

Andres Pirela, MD
Nephrology, Wake Forest, Winston – Salem, NC

Salomon Poliwoda, MD
Anesthesiology, Mount Sinai Medical Center, FL

Samuel Rapaka, DO
Chief Resident, Mount Sinai Medical Center, FL

Paola Rios Florez, MD
Endocrinology, University of Miami/ Jackson Healthcare System, Miami, FL

Anita Singh, DO
Pulmonology/ Critical Care, University of Miami/ Jackson Healthcare System, Miami, FL

Francisco Ujueta, MD
Cardiology, Mount Sinai Medical Center, FL

Publications and Presentations

Publications (last 3 years)

1. Alam ZH, Ujueta F, Arenas IA, Nigra AE, Navas-Acien A, Lamas GA. Urinary metal levels after repeated edetate disodium infusions: Preliminary findings. International Journal of Environmental Research and Public Health. 2020;17:4684.
2. Anderson, M., Winter, M., Jorge, V., & Dourado, C.. (2020, June 09). Development of new cold antibodies in a patient with a history of warm autoimmune hemolytic anemia. http://dx.doi.org/10.1136/bcr-2019-232224,
3. Skopis M, Elghawy AA, Pociurko B, Oh KS, Bag-Ozbek A. Pyoderma Gangrenosum Associated with Limited Cutaneous Systemic Sclerosis: A Rare Case with Literature Review [published online ahead of print, 2020 Jul 16]. Clin Rheumatol. 2020; 10.1007/s10067-020-05285-z.
4. Navas-Acien, A., Alam, Z.H., Domingo-Relloso, A., Ujueta, F., Lamas, G.A.. Urinary Metal Levels after Repeated Chelation with Edetate Disodium: Additional Evidence in Support of Metals as Cardiovascular Risk Factors. Circulation. 2020, Mar;141(Suppl_1): 452.
5. Skopis M, Bag Ozbek A. Maintenance with Rituximab in ANCA Vasculitis. Vessel Plus. July 2020. https://vpjournal.net/special_detail/492
6. Elghawy AA, Skopis M, Davis J, Bag Ozbek A. Angiostrongyliasis Infection Masquerading as Granulomatosis with Polyangiitis: A Case-Based Review. Rheumatology International. 2020, May; 40(7)1171-1176. PMID: 32424614
7. Alam Z.H., Ujueta F., Arenas I.A., Nigra A.E., Navas-Acien A., Lamas G.A.. (2020, April 14). A Modifiable Risk Factor for Cardiovascular Disease: Exploratory Study of Urinary Metal Levels After Repeated Edetate Disodium Infusions.
8. Adams, T. S.; Schupp, J. C.; Poli, S.; Ayaub, E. A.; Neumark, N.; Ahangari, F.; Chu, S. G.; Raby, B. A.; DeIuliis, G.; Januszyk, M.; Duan, Q.; Arnett, H. A.; Siddiqui, A.; Washko, G. R.; Homer, R.; Yan, X.; Rosas, I. O.; Kaminski, N. Single-Cell RNA-Seq Reveals Ectopic and Aberrant Lung-Resident Cell Populations in Idiopathic Pulmonary Fibrosis. Sci. Adv. 2020, 6 (28), eaba1983. https://doi.org/10.1126/sciadv.aba1983.
9. Lewis EF, Ujueta F, Lamas GA, Rosenberg Y, Boineau R, Roberts RS, Mark DB, Nahin RL, Goertz C, Stylianou M, Lee KL. Differential outcomes with edetate disodium-based chelation among patients with anterior vs non-anterior myocardial infarction in TACT. Cardiovascular Revascularization Medicine. 2020. doi: 10.1016/j.carrev.2020.04.005
10. Escolar E, Ujueta F, Kim H, Mark DB, Rosenberg Y, Boineau R, Nahin RL, Goertz C, Lindblad L, Lee KL, Lamas GA. The benefit of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT). Journal of Diabetes and its Complications. 2020. https://doi.org/10.1016/j.jdiacomp.2020.107616
11. Singh, A, Porras A, Ujueta F, Lo Presti S, Camps N. Obstructive heart failure with Cardiobacterium hominis infective endocarditis. IDCases. 2020;21:e00845.
12. Cortez N, Berzosa M, Mahfouz M, Dvir K, Galarza-Fortuna G, Ben-David K. Diagnosis and treatment of metastatic disease to the pancreas. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2020, Jul; 10(00). Cited in PubMed; PMID: 32614661.
13. Cortez N, Berzosa M, Jacobs A, Bloom M. Collagenous Gastritis: an unusual presentation with tubular shaped stomach. Journal of Investigative Medicine High Impact Case Reports. 2020, Jun; 8: 1-3. Cited in PubMed; PMID 32720809.
14. Arayo-Accro L, Cortez N, Aitcheson G, Hosein P.J, Carrion AF, Pinheiro PS, Jones P.D. Race and intrahepatic cholangiocarcinoma: disparities in management and survival. Gastroenterology 2020; 158(6):S-1399.
15. Dvir K, Galarza-Fortuna G, Willet A, Febres-Aldana C, Cortez N, Rapaka S, Coombs A, Ben-David K, Goldberg R, Schwartz M. A rare case of light chain amyloidosis of the gastrointestinal tract. Case Reports in Surgery. 2020, Jun; 2020: 1-4. Cited in PubMed; PMID: 32665873.
16. Chu, S. G.; Poli De Frias, S.; Raby, B. A.; Rosas, I. O. An RNA-Seq Primer for Pulmonologists. Eur Respir J 2020, 55 (1), 1801625. https://doi.org/10.1183/13993003.01625-2018.
17. Chu, S. G.; Poli De Frias, S.; Sakairi, Y.; Kelly, R. S.; Chase, R.; Konishi, K.; Blau, A.; Tsai, E.; Tsoyi, K.; Padera, R. F.; Sholl, L. M.; Goldberg, H. J.; Mallidi, H. R.; Camp, P. C.; El-Chemaly, S. Y.; Perrella, M. A.; Choi, A. M. K.; Washko, G. R.; Raby, B. A.; Rosas, I. O. Biobanking and Cryopreservation of Human Lung Explants for Omic Analysis. Eur Respir J 2020, 55 (1), 1801635. https://doi.org/10.1183/13993003.01635-2018.
18. Tsukui, T.; Sun, K.-H.; Wetter, J. B.; Wilson-Kanamori, J. R.; Hazelwood, L. A.; Henderson, N. C.; Adams, T. S.; Schupp, J. C.; Poli, S. D.; Rosas, I. O.; Kaminski, N.; Matthay, M. A.; Wolters, P. J.; Sheppard, D. Collagen-Producing Lung Cell Atlas Identifies Multiple Subsets with Distinct Localization and Relevance to Fibrosis. Nat Commun 2020, 11 (1), 1920. https://doi.org/10.1038/s41467-020-15647-5.
19. Solomon, J. J.; Matson, S.; Kelmenson, L. B.; Chung, J. H.; Hobbs, S. B.; Rosas, I. O.; Dellaripa, P. F.; Doyle, T. J.; Poli, S.; Esposito, A. J.; Visser, A.; Marin, A. I.; Amigues, I.; Fernández Pérez, E. R.; Brown, K. K.; Mahler, M.; Heinz, D.; Cool, C.; Deane, K. D.; Swigris, J. J.; Demoruelle, M. K. IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis. Chest 2020, 157 (6), 1513–1521. https://doi.org/10.1016/j.chest.2019.12.005.
20. Muus, C.; Luecken, M. D.; Eraslan, G.; Waghray, A.; Heimberg, G.; Sikkema, L.; Kobayashi, Y.; Vaishnav, E. D.; Subramanian, A.; Smilie, C.; Jagadeesh, K.; Duong, E. T.; Fiskin, E.; Triglia, E. T.; Ansari, M.; Cai, P.; Lin, B.; Buchanan, J.; Chen, S.; Shu, J.; Haber, A. L.; Chung, H.; Montoro, D. T.; Adams, T.; Aliee, H.; Samuel, J.; Andrusivova, A. Z.; Angelidis, I.; Ashenberg, O.; Bassler, K.; Bécavin, C.; Benhar, I.; Bergenstråhle, J.; Bergenstråhle, L.; Bolt, L.; Braun, E.; Bui, L. T.; Chaffin, M.; Chichelnitskiy, E.; Chiou, J.; Conlon, T. M.; Cuoco, M. S.; Deprez, M.; Fischer, D. S.; Gillich, A.; Gould, J.; Guo, M.; Gutierrez, A. J.; Habermann, A. C.; Harvey, T.; He, P.; Hou, X.; Hu, L.; Jaiswal, A.; Jiang, P.; Kapellos, T.; Kuo, C. S.; Larsson, L.; Leney-Greene, M. A.; Lim, K.; Litviňuková, M.; Lu, J.; Ludwig, L. S.; Luo, W.; Maatz, H.; Madissoon, E.; Mamanova, L.; Manakongtreecheep, K.; Marquette, C.-H.; Mbano, I.; McAdams, A. M.; Metzger, R. J.; Nabhan, A. N.; Nyquist, S. K.; Penland, L.; Poirion, O. B.; Poli, S.; Qi, C.; Queen, R.; Reichart, D.; Rosas, I.; Schupp, J.; Sinha, R.; Sit, R. V.; Slowikowski, K.; Slyper, M.; Smith, N.; Sountoulidis, A.; Strunz, M.; Sun, D.; Talavera-López, C.; Tan, P.; Tantivit, J.; Travaglini, K. J.; Tucker, N. R.; Vernon, K.; Wadsworth, M. H.; Waldman, J.; Wang, X.; Yan, W.; Zhao, W.; Ziegler, C. G. K.; The NHLBI LungMAP Consortium; The Human Cell Atlas Lung Biological Network. Integrated Analyses of Single-Cell Atlases Reveal Age, Gender, and Smoking Status Associations with Cell Type-Specific Expression of Mediators of SARS-CoV-2 Viral Entry and Highlights Inflammatory Programs in Putative Target Cells; preprint; Bioinformatics, 2020. https://doi.org/10.1101/2020.04.19.049254.
21. Hunninghake, G. M.; Quesada-Arias, L. D.; Carmichael, N. E.; Martinez Manzano, J. M.; Poli De Frías, S.; Baumgartner, M. A.; DiGianni, L.; Gampala-Sagar, S. N.; Leone, D. A.; Gulati, S.; El-Chemaly, S.; Goldberg, H. J.; Putman, R. K.; Hatabu, H.; Raby, B. A.; Rosas, I. O. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis. Am J Respir Crit Care Med 2020, 201 (10), 1240–1248. https://doi.org/10.1164/rccm.201908-1571OC.
22. Schupp, J. C.; Khanal, S.; Gomez, J. L.; Sauler, M.; Adams, T. S.; Chupp, G. L.; Yan, X.; Poli, S.; Montgomery, R. R.; Rosas, I. O.; Dela Cruz, C. S.; Bruscia, E. M.; Egan, M. E.; Kaminski, N.; Britto, C. J. Single Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis; preprint; Respiratory Medicine, 2020. https://doi.org/10.1101/2020.03.06.20032292.
23. Trabolsi, A., Winter, M.E., Rodriguez, E.. Proton pump inhibitors and response to immune check-point inhibitors: Single center study [Abstract]. Journal of Clinical Oncology: An American Society of Clinical Oncology Journal. 2019, Apr; 37(15): e14092.
24. Alam, ZH, Ujueta F, Lamas GA. Potential role of edetate disodium-based therapy in the treatment of atherosclerosis in patients with diabetes. Current Research in Diabetes & Obesity Journal. 2019; 11(3):555811.
25. Tsoyi, K.; Osorio, J. C.; Chu, S. G.; Fernandez, I. E.; De Frias, S. P.; Sholl, L.; Cui, Y.; Tellez, C. S.; Siegfried, J. M.; Belinsky, S. A.; Perrella, M. A.; El-Chemaly, S.; Rosas, I. O. Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness. Am J Respir Cell Mol Biol 2019, 60 (6), 659–666. https://doi.org/10.1165/rcmb.2018-0118OC.
26. Raredon, M. S. B.; Adams, T. S.; Suhail, Y.; Schupp, J. C.; Poli, S.; Neumark, N.; Leiby, K. L.; Greaney, A. M.; Yuan, Y.; Horien, C.; Linderman, G.; Engler, A. J.; Boffa, D. J.; Kluger, Y.; Rosas, I. O.; Levchenko, A.; Kaminski, N.; Niklason, L. E. Single-Cell Connectomic
27. Analysis of Adult Mammalian Lungs. Sci. Adv. 2019, 5 (12), eaaw3851. https://doi.org/10.1126/sciadv.aaw3851.
28. Ujueta F, Arenas IA, Diaz D, Yates T, Beasley R, Navas-Acien A, Lamas GA. Cadmium level and severity of peripheral artery disease in patients with coronary artery disease. European Journal of Preventive Cardiology. 2019;26(13):1456-1458.
29. Ujueta F, Arenas IA, Yates T, Beasley R, Diaz D, Lamas GL. Edetate disodium-based treatment in a patient with diabetes and critical limb ischemia after unsuccessful peripheral arterial revascularization: A case report. Clinical Diabetes. 2019;37(3):294-297.
30. Ujueta F, Arenas IA, Escolar E, Diaz D, Boineau R, Mark DB, Golden P, Lindblad L, Kim H, Lee KL, Lamas GA. The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT). Journal of Diabetes and its Complications. 2019;33(7):490-494.
31. Ujueta F, Yates T, Olivieri B, Beasley R, Lamas GA. Potential role for edetate-based infusions as adjunctive treatment for limb salvage in patients with critical limb ischemia. CLI Global Journal. September 2019.
32. Ujueta F, Vozzi C, Vozzi L, Lamas GA. Edetate disodium-based treatment in a woman with diabetes and critical limb ischemia scheduled for lower extremity amputation. Cureus. 2019;11(11):e6142.
33. Porudominsky R, Ujueta F, Olivieri B, Beasley R, Lamas GA. Does edetate disodium reduce cost of care of patients with diabetes and critical limb ischemia? Journal of Vascular and Invasive Radiology. December 2019. [Meeting Abstract]
34. Arenas IA, Ujueta F, Diaz D, Yates T, Olivieri B, Beasley R, Lamas GA. Limb preservation using edetate disodium-based chelation in patients with diabetes and critical limb ischemia: an open label study. Cureus. 2019;11(12):e6477. DOI:10.7759/cureus.6477.
35. Porudominsky R, Ujueta F Arenas I, Lamas GA. Preliminary Cost Estimates of Edetate Disodium Infusions for Critical Limb Ischemia in Patients with Diabetes Mellitus. Vascular Disease Management. July 2020. Vol 17- Issue 7
36. Cortez N, Mahmoud M, Berzosa M. The Use of a New Hemostatic Powder in Refractory Pseudocyst Wall Bleeding. American Journal of Gastroenterology: October 2019 – Volume 114- Issue-p S1075.
37. Cortez N, Mahmoud M, Berzosa M, Nasir A.B. Successful EUS-Guided Treatment of Duodenal Varices with Coil Embolization. American Journal of Gastroenterology: October 2019 – Volume 114- Issue – p S1230-S1231.
38. Cortez N, Mahmoud M, Berzosa M, Bloom M. A Case of Collagenous Gastritis: A Rare Entity. American Journal of Gastroenterology: October 2019 – Volume 114 – Issue – p S1525-S1526.
39. Gill, I. Ugalde, CA. Febres-Aldana, C. Tuda. Fluoroquinolone resistant tuberculosis: A case report and literature review. Respir Med Case Rep. 2019 Mar 29;27:100829. doi: 10.1016/j.rmcr.2019.100829.
40. Ujueta F, Lamas GA. Toxic metal chelation with edetate disodium in a patient with diabetes and critical limb ischemia. Vascular Disease Management. June 2019;16(6): E79-E81
41. Ujueta F, Arenas IA, Escolar E, Diaz D, Boineau R, Mark DB, Golden P, Lindblad L, Kim H, Lee KL, Lamas GA. The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT). Journal of Diabetes and its Complications. 2019. https://doi.org/10.1016/j.jdiacomp.2019.04.005
42. Ujueta F, Arenas IA, Yates T, Beasley R, Diaz D, Lamas GL. Edetate disodium-based treatment in a patient with diabetes and critical limb ischemia after unsuccessful peripheral arterial revascularization: A case report. Clinical Diabetes. 2019; https://doi.org/10.2337/cd18-0059.
43. Shah B, Newman JD, Woolf K, Ganguzza L, Fisher E, Allen N, Larigakis J, Guo Y, Gianos E, Ujueta F, Slater J. Anti-Inflammatory Effects of a Whole-Food Plant-Based Vegan Diet Versus the American Heart Association-Recommended Diet in Patients with Coronary Artery Disease: Effect of a Vegan versus AHA DiEt in Coronary Artery Disease (EVADE CAD) trial. American Heart Association (AHA). Circulation. 2018;136: A23081. [Meeting Abstract]
44. Guo T, Diacou A, Nomaru H, McDonald-McGinn DM, Hestand M, Demaerel W, Zhang L, Zhao Y, Ujueta F, Shan J, Montagna C, Zheng D, Crowley TB, Kushan-Wells, L, Bearden CE, Kates WR, Gothelf D, Schneider M, Eliez S, Breckpot J, Swillen A, Vortsman J, Zackai E, Gonzalez FB, Repetto M, Emanuel BS, Bassett AS, Vermeesch JR, Marshall CR, Morrow BE. Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2. Hum Mol Genet. 2018;27(7):1150-1163.
45. Suraci N, Horvath SA, Urina D, Rosen G, Santana O. Quadricuspid aortic valve: Case series and review of literature. Echocardiography. 2018;00:1–5. https:// doi.org/10.1111/echo.14240.
46. Ugalde, D. Pirela. Fungating breast mass in a developed country. BMJ Case Rep. 2018. doi: 10.1136/bcr-2018-224727.
47. Arenas IA, Ujueta F, Diaz D, Navas-Acien A, Beasley R, Yates T, Olivieri B, Lamas GA. Pilot study of Edetate Disodium-based chelation in diabetics with critical limb ischemia. Circulation. 2018;138: A13005
48. I. Ugalde, M. Bello Segura, A. Ciment. The Forgotten Electrolyte; When Hypercalcemia Manifest as gait Instability and Altered Mental Status. BMJ Case Rep. 2018. doi: 10.1136/bcr-2017-224089.
49. I. Ugalde, I. Anjum, S. Lo Presti, A. Tolentino. Myocardial Infarction Presenting as Ear Fullness and Pain. J Investig Med High Impact Case Rep. 2018. 3(6). doi: 10.1177/2324709618761753
50. Shah B, Newman JD, Woolf K, Ganguzza L, Fisher E, Allen N, Larigakis J, Guo Y, Gianos E, Ujueta F, Slater J. Anti-Inflammatory Effects of a Whole-Food Plant-Based Vegan Diet Versus the American Heart Association-Recommended Diet in Patients with Coronary Artery Disease: Effect of a Vegan versus AHA DiEt in Coronary Artery Disease (EVADE CAD) trial. American Heart Association (AHA). Circulation. 2018;136: A23081
51. Ujueta F, Berger JS, Smilowitz N. Coronary Angiography in Patients with Perioperative Myocardial Injury after Non-Cardiac Surgery. Journal of Invasive Cardiology. 2018;30(9): E75-E77.
52. Association of QT Interval with Mortality by Kidney Function: Results from the National Health and Nutrition Examination Survey (NHANES). Rehan Malik, MD; Sehrish Waheed MD; Deepak Parasharad, MD; Jorge Perez, MD; Salman Waheed, MD, MPH, Open Heart – 2017
53. Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy. Julio G. Peguero, MD; Saberio Lo Presti, MD; Jorge Perez, MD; Omar Issa, DO; Juan C. Brenes, MD; Alfonso Tolentino, MD, Journal of American College of Cardiology, JACC – 2017
54. New Criteria for LVH Should Be Evaluated Against Age. Julio G. Peguero, MD; Saberio Lo Presti, MD; Jorge Perez, MD; Omar Issa, DO; Juan C. Brenes, MD; Alfonso Tolentino, MD, Journal of American College of Cardiology, JACC – 2017
55. Reply: Electrocardiographic Criteria for Diagnosing Left Ventricular Hypertrophy and Predicting Mortality in Patients With Aortic Stenosis. Julio G. Peguero, MD; Saberio Lo Presti, MD; Jorge Perez, MD; Omar Issa, DO; Juan C. Brenes, MD; Alfonso Tolentino, MD, Journal of American College of Cardiology, JACC – 2017
56. Reply: Adjustments of Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy. Julio G. Peguero, MD; Saberio Lo Presti, MD; Jorge Perez, MD; Omar Issa, DO; Juan C. Brenes, MD; Alfonso Tolentino, MD, Journal of American College of Cardiology, JACC – 2017
57. Left Atrial Size and Heart Failure Hospitalization in Patients with Diastolic Dysfunction and Preserved Ejection Fraction.J Cardiovasc Echogr. 2017 Jan-Mar;27(1):1-6. doi: 10.4103/2211-4122.199064. Issa O1, Peguero JG1, Podesta C1, Diaz D2, De La Cruz J2, Pirela D2, Brenes JC1.
58. Metastatic Endobronchial Ameloblastoma. Kanagarajah P, Ciment LM, Ciment AJ, Clum SR, Rumbak MJ. J Bronchology Interv Pulmonol. 2017 Feb 6. doi: 10.1097/LBR.0000000000000365. [Epub ahead of print]
59. Left Atrial Size and Heart Failure Hospitalization in Patients with Diastolic Dysfunction and Preserved Ejection Fraction. Issa O, Peguero JG, Podesta C, Diaz D, De La Cruz J, Pirela D, Brenes JC. J Cardiovasc Echogr. 2017 Jan-Mar;27(1):1-6. doi: 10.4103/2211-4122.199064.

General

17 categorical and 4 preliminary positions are offered at Mount Sinai Medical Center’s Internal Medicine Residency Program each year.

Mount Sinai Medical Center participates and accepts applications only through ERAS (Electronic Residency Application Service). In addition, your application will only be considered if you are enrolled in the National Resident Matching Program (NRMP). You must contact your medical school for delivery of your application, transcripts, Dean’s letter, and faculty recommendations to our program, electronically.

PLEASE NOTE THAT THE DEADLINE FOR APPLYING THROUGH ERAS IS November 1st.

NRMP#:
1105140C0 Categorical Program
1105140P0 Preliminary Program

ACGME Program ID#:
1401112101

Required Documents for Application

Letters of Recommendation:

• Three letters of Recommendation are required to apply. One letter should be from the Internal Medicine clerkship director and/or the chairman of the department of Internal Medicine
• Dean’s Letter / MSPE is a mandatory requirement
• We do not accept H1 Visas at this time

International Medical Graduates: All applicants are required to provide the requirements listed below:

• All applicants MUST apply through ERAS and be in the NRMP Match
• Medical School Transcripts
• Applicants should have graduated from medical school within the past five years.
• Applicants must have passing scores on all USMLE Steps inculding the Clinical Skills (CS) to obtain an interview.
• Applicants must have excellent English comprehension and speaking skills.

Interview Process

Upon receipt of the completed application, our selection committee will review all materials. Invitations for interviews will be offered via e-mail from Carlene Gauntlett-Baroody, Program Coordinator.

Due to COVID-19, all interviews will be conducted virtually with interview dates starting in November.

Inquiries may be directed to Carlene Gauntlett-Baroody, Program Coordinator, via e-mail at Carlene.Baroody@msmc.com or by phone at 305-674-2053

Please be aware that Mount Sinai Medical Center has a zero tolerance policy for smoking. Prior to gaining appointment as a resident, all persons will need to undergo testing for non-prescribed substances and nicotine. Offers of appointment to prospective employees who test positive for nicotine will be rescinded.